These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 25739327)

  • 1. [Fertility preservation in breast cancer patients: the state of art in 2014?].
    Comtet M; Sonigo C; Valdelièvre C; Sermondade N; Sifer C; Grynberg M
    Bull Cancer; 2015 May; 102(5):443-53. PubMed ID: 25739327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oncofertility and breast cancer].
    Sonigo C; Grynberg M; Bringer S; Sermondade N
    Bull Cancer; 2019 Dec; 106(12S1):S43-S52. PubMed ID: 32008738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fertility preservation in adolescents and young adults with cancer].
    Rousset-Jablonski C; Chevillon F; Dhedin N; Poirot C
    Bull Cancer; 2016 Dec; 103(12):1019-1034. PubMed ID: 27817861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fertility preservation in women of the childbearing age: Indications and strategies].
    Bénard J; Calvo J; Comtet M; Benoit A; Sifer C; Grynberg M
    J Gynecol Obstet Biol Reprod (Paris); 2016 May; 45(5):424-44. PubMed ID: 27021926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.
    Fatum M; McVeigh E; Child T
    Hum Fertil (Camb); 2013 Dec; 16(4):235-40. PubMed ID: 23863119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Practical clinical aspects of oocyte vitrification for fertility preservation].
    Courbiere B; Decanter C
    Gynecol Obstet Fertil; 2014 Sep; 42(9):653-6. PubMed ID: 25164159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility after breast cancer treatment.
    Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New trends in female fertility preservation: in vitro maturation of oocytes.
    Berwanger AL; Finet A; El Hachem H; le Parco S; Hesters L; Grynberg M
    Future Oncol; 2012 Dec; 8(12):1567-73. PubMed ID: 23231518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preservation of fertility in children with cancer].
    de Lambert G; Poirot C; Guérin F; Brugières L; Martelli H
    Bull Cancer; 2015 May; 102(5):436-42. PubMed ID: 25818928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.
    Bénard J; Duros S; El Hachem H; Sonigo C; Sifer C; Grynberg M
    Future Oncol; 2016 Jul; 12(14):1731-41. PubMed ID: 27184037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
    Decanter C; Robin G
    Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
    Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
    Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
    Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
    Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer and fertility: critical review, considerations and perspectives].
    This P
    Bull Cancer; 2008 Jan; 95(1):17-25. PubMed ID: 18230566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
    Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
    Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Do controlled ovarian hyperstimulations and cryopreservations promote recurrences after breast cancer?].
    Bergamini ML; Maugard CM; Mathelin C
    Gynecol Obstet Fertil Senol; 2017 Mar; 45(3):172-179. PubMed ID: 28259703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.